TABLE 2.
Anti-tuberculous activity of IMB-0283.
| Mtb strains | Drug sensitivity background∗ | MIC (μg/mL) | ||||||
| INH | RMP | EMB | STR | CPM | KAN | OFX | ||
| H37RV | S | S | S | S | S | S | S | 0.5 |
| FJ05349 | S | S | S | S | S | S | S | 0.5 |
| FJ05060 | S | S | S | S | S | S | S | 0.5 |
| FJ05195 | R | R | R | R | S | R | R | 4.0 |
| FJ05120 | R | R | S | S | S | S | S | 2.0 |
| FJ05189 | R | R | S | S | S | S | S | 1.0 |
| xz | R | R | S | R | R | S | R | 4.0 |
INH, isoniazid; RMP, rifampin; EMB, ethambutol; STR, streptomycin; CPM, cefpiramide; KAN, kanamycin; OFX, ofloxacin; MIC, minimum inhibitory concentrations; S, sensitive; R, resistant.